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Introduction
Cellular damage after reperfusion of  previously viable ischaemic 
tissues in lower extremity is a common and critical clinical inci-
dent. Reperfusion of  an acutely ischemic tissue may, paradoxi-
cally, lead to systemic complications that are associated with sig-
nificant morbidity and mortality rates. As reperfusion progresses 
generally systemic inflammatory response syndrome and multiple 
organ failure (kidney, respiratory and circulatory system, etc.) fol-
low local edema and muscle necrosis [1-5].  
Pregabalin, a GABA analogue, is a potent new generation antiepi-
Effect of  Different Doses of  Pregabalin on Erythrocyte Deformability in Rats with Lower Limb 
Ischemia Reperfusion Injury
           Research Article
Özer A1, Çomu FM2, Demirtaş H3, Kılıç Y1, Mardin B1, Öztürk L4, Iriz E1, Arslan M5*, Küçük A6
1 Department of  Cardiovascular Surgery, Gazi University Medical Faculty, Ankara, Turkey.
2 Department of  Physiology, Kırıkkale University Medical Faculty, Kirikkale, Turkey.
3 Department of  Cardiovascular Surgery, Yüksek Ihtisas Hospital, Kirikkale, Turkey.
4 Department of  Anaesthesiology and Reanimation, Yıldırım Beyazit University Medical Faculty, Ankara, Turkey.
5 Department of  Anaesthesiology and Reanimation, Gazi University Medical Faculty, Ankara, Turkey.
6 Department of  Physiology, Dumlupinar University Medical Faculty, Kütahya, Turkey.
Abstract
Aim/Introduction: Acute ischemia reperfusion (IR) injury observed in the lower extremities occurs especially when a 
temporary cross-clamp is applied to the abdominal aorta during aortic surgery. Preoperative pregabalin has been used as a 
part of  multimodal analgesia in postoperative pain treatment in recent years. Pregabalin has become one of  the increasingly 
common agents in postoperative analgesia. In this study, we aimed to investigate the effect of  pregabalin on erythrocyte 
deformability in rats undergoing IR.
Materials and Methods: 24 male Wistar albino rats weighing between 200-250 g were used in the study. Rats were ran-
domly divided into 4 groups of  6 rats each (Control, Ischemia-Reperfusion (IR), IR-Pregabalin 50 mg (50 mg.kg-1), IR-
Pregabalin 200 mg (200 mg.kg-1). Pregabalin was administered intraperitoneally 30 min before the procedure. An atraumatic 
microvascular clamp was placed across the infrarenal abdominal aorta in the IR groups.  Following 120 min of  ischemia, 
the clamp was removed and reperfusion was continued for 120 min. All rats were euthanized by intraperitoneal administra-
tion of  ketamine (100 mg•kg−1) and taking blood from the abdominal aorta. Erythrocytes were seperated from heparinized 
whole blood samples. Deformability measurements were made in erythrocyte suspensions in phosphate buffered saline. 
A constant flow filtrometer system was used to measure erythrocyte deformability and relative resistance was calculated.
Results: It was found that the formation of  ischemia reperfusion increases the relative resistance according to the control 
group (p < 0.0001). It was determined that application of  pregabalin 50 or 200 mg did not change erythrocyte deformability 
in ischemia reperfusion-induced rats  (p = 0.632, p = 0.811).
Conclusion: The administration of  50 or 200 mg of  pregabalin has no negative effect on the erythrocyte deformability in 
ischemia reperfusion-induced rats. We think that pregabalin can be safely used for analgesia in the cases of  IR. However, 
these findings should be supported by clinical and experimental studies carried out in more detailed and broader series.
Keywords: Ischemia Reperfusion; Pregabalin; Different Dose; Erythrocyte Deformability.
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leptic drug that is used for the treatment of  partial onset seizures, 
painful diabetic neuropathy, and post-herpetic neuralgia [6]. It 
binds to the α2δ subunit of  the voltage-dependent calcium chan-
nel and does not bind to the protein. Pregabalin does not interact 
with liver enzymes and 95% of  it is excreted by kidneys. Besides 
these clinical indications, it has some new properties that we need 
to focus on. Pregabalin has been used to protect against IR injury 
in many organs [1, 7, 8].
Benefits of  pregabalin use to prevent local and distal tissue injury 
due to IR has been well documented so far. However, not much 
is known about its protective effect on erythrocyte deformability 
following IR injury. The primary aim of  this study was to investi-
gate deformability changes and the role of  pregabalin in prevent-
ing these changes in the erythrocytes of  rats in an experimental 
model of  lower limb muscle IR injury.
Materials and Methods
Animals and Experimental Protocol
This study was carried out in Gazi University Physiology Labora-
tory with the approval of  the Ethics Committee of  Experimental 
Animals of  our university. All of  the procedures were performed 
according to accepted standards of   Guide for the Care and Use 
of  Laboratory Animals. 
In our study, 24 Wistar Albino rats weighing between 250 and 300 
g, raised under the same environmental conditions, were used. 
The rats were kept under 20-21°C at cycles of  12-hour daylight 
and 12-hour darkness and had free access to food until 2 hours 
before the anesthesia procedure. The animals were randomly 
separated into four groups, each containing 6 rats. Midline lapa-
ratomy was done under general anesthesia.
Control group: A midline laparotomy was performed without 
any extra surgical intervention. After 2 hours of  follow-up blood 
sample was collected and then animals were sacrificed.
I/R group: Midline laparotomy was performed in the same 
way. Infrarenal aorta was clamped for 2 hours. The clamp was 
removed and then reperfusion was started. Reperfusion lasted for 
two more hours. In the end after blood sampling from their ab-
dominal aorta rats were sacrificed. 
I/R group with pregabalin 50 mg: Similiar steps were followed 
as mentioned above but in addition to the procedure pregabalin 
was given (50 mg.kg-1)  intraperitoneally for 30 minutes before is-
chemia period. After collecting blood samples rats were sacrificed 
at the end of  2 hours reperfusion period.
I/R group with pregabalin 200 mg: Similiar steps were fol-
lowed as mentioned above but in addition to the procedure pre-
gabalin was given (200 mg.kg-1) intraperitoneally for 30 minutes 
before ischemia period. After collecting blood samples rats were 
sacrificed at the end of  2 hours reperfusion period.
Rats were anesthetized with ketamine (100 mg.kg−1, intraperito-
neally) and intracardiac blood samples were collected. Erythro-
cyte packs were prepared using heparinized total blood samples. 
Erythrocytes packs were mixed with phosphate buffered saline 
(PBS) buffer to generate a suspension with the value of  5% HCT. 
Those erythrocyte suspensions were used for the measurement 
of  deformability.
Deformability Measurements
To prevent hemolysis samples of  blood were collected very care-
fully and measurement process was done rapidly. Collected blood 
was centrifuged at 1000 rpm for ten minutes. Blood plasma in the 
upper phase and the buffy coat, which is a thin layer of  leukocytes 
mixed with platelets in the middle on erythrocytes were removed. 
Isotonic PBS buffer was added to collapsing erythrocytes and 
this mixture was centrifuged at 1000 rpm for ten minutes. Liquid 
on the upper surface was taken. Washing process was repeated 
three times and finally pure red cell packs were obtained. Eryth-
rocyte suspensions with 5 % hematocrit in phosphate buffered 
saline (PBS) buffer were used to do deformability measurements. 
Erytrocytes were collected and then deformability measurements 
were done at 22ºC. 
Erytrocytes deformability was measured by the constant-current 
filtrometre system . Samples were prepared as 10 ml of  erytrocytes 
suspension and PBS buffer before measurement. The infusion 
pump was set at 1.5 ml/min for a constant rate of  flow. A 28 mm 
nucleoporin polycabonate filter with a 5 µm pore diameter was 
used  Consisting pressure changes while the erythrocytes passing 
through from the filter were detected by the pressure transducer 
and the data was transferred to computer with the help of  MP 30 
data equation systems (Biopac Systems Inc, Commat, USA). At 
different times pressure changes were measured by using relevant 
computer programs for calculations. Pressure calibration of  the 
system was performed each time before measuring the samples. 
After buffer (PT) was passed  through the filtration system the 
erythrocytes (PE) were passed secondly. Pressure variations were 
measured. By relating the pressure value of  erythrocytes suspen-
sion to pressure value of  buffer the relative refractory period val-
ue (Rrel) was calculated. The deformability index was interpreted 
as Rrel was increasing the ability of  erythrocyte deformability was 
affected adversely.
Statistical Analysis
All the data were processed by variance analysis in SPSS 17.0 for 
Windows statistical software. A P-value less than 0.05 was consid-
ered statistically important. The data were expressed as mean ± 
standard deviation. Variance analysis and Kruskal-Wallis test were 
used to evaluate the data. Mann Whitney U test with Bonferroni 
correction were used to evaluate the variables with significance.
Results
The study showed that compared to control and IR groups rela-
tive resistance, a marker of  erythrocyte deformability, was in-
creased significantly by IR (p < 0.0001), (Figure). The values of  
the control group were significantly lower than those of  the IR, 
IR-P 50 and IR-P 200 mg groups (p < 0.0001, p < 0.0001, p < 
0.0001, respectively). It was determined that application of  pre-
gabalin 50 or 200 mg did not change erythrocyte deformability in 
IR-induced rats (p = 0.632, p = 0.811, respectively).
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Discussion
Pregabalin is a structural analog of  gamma-aminobutyric acid and 
has analgesic, anticonvulsant, anxiolytic and opioid-sparing ef-
fects. Pregabalin is a gabapentin derivative and has superior phar-
macokinetic activity although it shows similar effect [8]. In animal 
studies, pregabalin, such as gabapentin, has also been shown to 
be effective in several models of  neuropathic pain, incisional and 
inflammatory injury [9]. There are studies showing that preop-
erative administration of  pregabalin reduces acute postoperative 
pain and analgesic consumption and the incidence of  chronic 
neuropathic pain [10, 11]. 
Pregabalin is a gamma-amino-butyric acid analog with anticonvul-
sant, anxiolytic and opioid-sparing properties. In a study of  epi-
lepsy patients, oxcarbazepine has been shown to increase erythro-
cyte deformability at a shear force of  0.95 Pa [12].
For being capable for carrying oxygen and vital molecules to the 
final organ capillaries and excretion of  metabolic wastes, eryth-
rocytes must be able to extend and curve to move in these ar-
eas.  This capacity, called as “deformability” is more important in 
microcirculation. Altered erythrocyte deformability changes both 
oxygen delivery capacity of  the erythrocytes and the survival of  
the circulating erythrocytes [13-15]. 
In addition to these data our findings indicate that in rats under-
going IR  erythrocyte deformability impairs and this impairment 
leads to disturbed microvascular perfusion and related problems. 
So we think that erythrocyte deformability measurement can be 
a useful parameter in IR injury. We also did not observe nega-
tive effect of  pregabalin on maintaining erythrocyte deformability 
during periods of  IR but we still think these promising results 
should further be supported by more detailed studies with larger 
volumes.
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Figure 1. Erythrocyte Deformability Index Values of  the Groups. Each Bar Represents the mean ± sd.
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